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Background
Blood entering the left ventricle (LV) through the left
atrio-ventricular valve (LAVV) and exiting through the
aorta is assumed to follow the most energy efficient
pathway. In patients with a corrected atrio-ventricular
septal defect (AVSD), this intra-cardiac blood flow path-
way may be altered, due to the restricted opening of the
LAVV. This might affect optimal LV function. Particle
tracing in 4DFlow MRI data enables quantitative evalua-
tion of the temporal distribution of blood particles in
the LV. We aimed to compare the LV intra-cardiac blood
flow pathway in corrected AVSD patients with that of
healthy subjects, using 4DFlow MRI and particle tracing
in the standard 16 segment model of the American Heart
Association (AHA).
Methods
Twenty five patients with a history of corrected AVSD
(mean age 23 ± 10 years) and 25 healthy subjects (21 ± 11
years) were included. Whole-heart 4DFlow MRI was
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Figure 1 An example of LV filling by using particle tracing, illustrating the difference between the blood flow pathway in a healthy
subject (A) and a patient with corrected AVSD (B) at time point 0.5. Colors indicate velocity (mm/s). Note the difference in apical filling.
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Figure 2 Particle distribution (expressed in particle percentage (pp) as the fraction of total particles released) at four time points in the
cardiac cycle at basal, mid and apical level, distributed according to standard 16-segment AHA model (1-16). Mean pp and standard
deviation are given in the diagrams, for clustered neighbouring segments. Gray scale coding represents the amount of pp. Statistical significance
between neighbouring segments and between patients and controls is expressed as follows: * = p < 0.05, ** = p < 0.01, ***p < 0.001. Segments:
1 Basal anterior, 2 Basal anterior septal, 3 Basal inferior septal, 4 Basal inferior, 5 Basal inferior lateral, 6 Basal anterior lateral, 7 Mid anterior, 8 Mid
anterior septal, 9 Mid inferior septal, 10 Mid inferior, 11 Mid inferior lateral, 12 Mid anterior lateral, 13 Apical anterior, 14 Apical septal, 15 Apical
inferior 16 Apical lateral.
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performed at 3T (Ingenia, Philips, The Netherlands) with
free breathing, three-directional velocity encoding of 150
cm/s in all, spatial resolution 2.3 × 2.3 × 3.0-4.2 mm 3 and
30 phases reconstructed over one cardiac cycle. Particles,
evenly distributed within the left atrium (LA), were
released at the end-systole and then followed over one car-
diac cycle using forward particle tracing (Figure 1). The
pathway of these particles was assessed from the temporal
particle distribution according to the standard AHA 16
segment model. The amount of particles per segment at a
time point, is expressed in particle percentage (pp), as the
fraction of total particles released at t = 0 (end systole) in
the LA. Differences in pp within subjects were compared
using paired t-test; differences between patient and con-
trols were compared using unpaired t-tests.
Results
In Figure 2, values for mean pp are presented for four typi-
cal time points. These diagrams reveal that firstly, in con-
trols and patients, the start of early filling (t = 0.1)
predominantly takes place laterally (p ≤ 0.04), followed
(t = 0.2) by filling in all segments. In patients, filling
through segments 1-4 is significantly lower (p < 0.001).
At the end of early filling (t = 0.4), mean pp in controls is
significantly higher (p < 0.001) in mid LV segments 7+8
(i.e. anterior). In patients, pp is significantly higher (p =
0.02) in segments 11+12 (i.e. lateral), and significantly
more particles (p = 0.01) reach into the apical segments,
especially anterior-lateral (p < 0.001). During systole (t =
0.8), particles move towards basal segments 1+2 towards
the aorta, but in patients, mean pp in segments 5+6 (i.e.,
lateral) is equally high as particles in these segments may
contribute to LAVV regurgitation.
Conclusions
With 4DFlow MRI and particle tracing, an altered pathway
in the intracardiac blood flow can be observed in patients
with a corrected AVSD, that might affect optimal LV
function.
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